← Human Trials & Peer-Reviewed Studies

Opioid dysregulation after biliopancreatic diversion: effect of naloxone on preprandial and postprandial growth hormone (GH)-releasing hormone-induced GH release in surgically induced weight loss

Plain-language guide to PMID 11288030 (2001): randomized clinical trial study of GHRH (Growth Hormone-Releasing Hormone), post-surgical inflammation and surgery recovery.

Key Facts

PMID
11288030
Journal
Metabolism: clinical and experimental
Year
2001
Study type
Clinical Trial
Authors
Mancini A et al. (10 authors)
DOI
10.1053/meta.2001.21680

What This Study Did, in Plain Language

What Was Tested

The paper reports a study of GHRH (Growth Hormone-Releasing Hormone) in the context of post-surgical inflammation and surgery recovery, published as a clinical trial.

Who Took Part

The age groups tagged for this paper are adults and middle-aged adults, women only.

How the Study Was Run

In design terms this was a randomized study.

Random assignment meant chance, not the researchers, decided who got GHRH (Growth Hormone-Releasing Hormone) and who got the comparison, which limits bias.

What Was Measured

PubMed files the paper under topics including Area Under Curve, Biliopancreatic Diversion, Body Mass Index, Endorphins, Growth Hormone-Releasing Hormone, Naloxone and Narcotic Antagonists.

What This Means in Plain Language

The paper is a randomized study of GHRH (Growth Hormone-Releasing Hormone) in people with post-surgical inflammation and surgery recovery.

The publication is from 2001 (Metabolism: clinical and experimental), a journal based in United States.

More context: the GHRH (Growth Hormone-Releasing Hormone) compound page, Post-surgical inflammation and surgery recovery research.

Our Notes on the Compound

GHRH (Growth Hormone-Releasing Hormone): The 44-amino-acid hypothalamic hormone that tells the pituitary to release growth hormone; sermorelin and tesamorelin are analogs.

Related Pages

Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.